DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,294 filers reported holding DANAHER CORPORATION in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,185,202,716 | +22.6% | 24,930,281 | +18.6% | 1.24% | +29.4% |
| Q2 2023 | $5,045,959,680 | +1.9% | 21,024,832 | +7.0% | 0.96% | -2.4% |
| Q1 2023 | $4,951,347,474 | -7.1% | 19,645,086 | -2.2% | 0.98% | -8.2% |
| Q4 2022 | $5,329,429,492 | +8.8% | 20,079,231 | +5.9% | 1.07% | +2.4% |
| Q3 2022 | $4,899,116,000 | +1.9% | 18,967,502 | -0.0% | 1.04% | +7.9% |
| Q2 2022 | $4,808,928,000 | -9.3% | 18,968,634 | +4.9% | 0.97% | +6.6% |
| Q1 2022 | $5,302,465,000 | -8.9% | 18,076,790 | +2.2% | 0.91% | -2.4% |
| Q4 2021 | $5,818,104,000 | +4.0% | 17,683,670 | -3.8% | 0.93% | -2.2% |
| Q3 2021 | $5,594,149,000 | +8.4% | 18,375,210 | -4.5% | 0.95% | +10.7% |
| Q2 2021 | $5,163,017,000 | +10.1% | 19,239,146 | -7.7% | 0.86% | +4.0% |
| Q1 2021 | $4,690,513,000 | -0.6% | 20,839,322 | -1.9% | 0.83% | -4.9% |
| Q4 2020 | $4,717,252,000 | -11.7% | 21,235,495 | -14.4% | 0.87% | -21.4% |
| Q3 2020 | $5,339,526,000 | +14.1% | 24,796,941 | -6.3% | 1.10% | +6.0% |
| Q2 2020 | $4,679,374,000 | +65.5% | 26,462,557 | +29.6% | 1.04% | +39.3% |
| Q1 2020 | $2,826,982,000 | -2.6% | 20,424,687 | +8.0% | 0.75% | +23.0% |
| Q4 2019 | $2,902,319,000 | +2.5% | 18,910,071 | -3.6% | 0.61% | -4.9% |
| Q3 2019 | $2,832,292,000 | -10.9% | 19,610,139 | -11.8% | 0.64% | -9.2% |
| Q2 2019 | $3,179,087,000 | -3.9% | 22,243,820 | -11.2% | 0.70% | -6.0% |
| Q1 2019 | $3,306,945,000 | +29.3% | 25,048,810 | +1.0% | 0.75% | +17.0% |
| Q4 2018 | $2,557,779,000 | -3.9% | 24,803,905 | +1.2% | 0.64% | +14.1% |
| Q3 2018 | $2,662,266,000 | +20.2% | 24,500,887 | +9.2% | 0.56% | +13.8% |
| Q2 2018 | $2,214,258,000 | +5.5% | 22,438,788 | +4.6% | 0.49% | +3.8% |
| Q1 2018 | $2,099,465,000 | +36.0% | 21,442,827 | +28.9% | 0.48% | +39.3% |
| Q4 2017 | $1,543,735,000 | +654.0% | 16,631,493 | +596.9% | 0.34% | +625.5% |
| Q3 2017 | $204,727,000 | +24.4% | 2,386,633 | +22.4% | 0.05% | +20.5% |
| Q2 2017 | $164,539,000 | -56.1% | 1,949,760 | -55.5% | 0.04% | -56.7% |
| Q1 2017 | $374,545,000 | +38.5% | 4,379,096 | +26.1% | 0.09% | +32.4% |
| Q4 2016 | $270,380,000 | -36.3% | 3,473,533 | -35.8% | 0.07% | -35.8% |
| Q3 2016 | $424,422,000 | -44.6% | 5,414,237 | -28.7% | 0.11% | -46.5% |
| Q2 2016 | $766,572,000 | +43.8% | 7,589,823 | +35.0% | 0.20% | +41.4% |
| Q1 2016 | $533,193,000 | +2.3% | 5,620,851 | +0.1% | 0.14% | +2.9% |
| Q4 2015 | $521,343,000 | +6.4% | 5,613,068 | -2.4% | 0.14% | -0.7% |
| Q3 2015 | $489,993,000 | -1.6% | 5,750,413 | -1.2% | 0.14% | +6.2% |
| Q2 2015 | $498,169,000 | -5.6% | 5,820,407 | -6.4% | 0.13% | -5.1% |
| Q1 2015 | $527,790,000 | -4.6% | 6,216,600 | -3.7% | 0.14% | -6.8% |
| Q4 2014 | $553,480,000 | +11.7% | 6,457,589 | -1.0% | 0.15% | +7.4% |
| Q3 2014 | $495,426,000 | -7.0% | 6,520,497 | -3.6% | 0.14% | -4.9% |
| Q2 2014 | $532,721,000 | +63.1% | 6,766,433 | +55.3% | 0.14% | +57.1% |
| Q1 2014 | $326,683,000 | -0.9% | 4,355,777 | +2.0% | 0.09% | -4.2% |
| Q4 2013 | $329,715,000 | +16.1% | 4,270,935 | +4.2% | 0.10% | +6.7% |
| Q3 2013 | $284,045,000 | +22.3% | 4,097,597 | +11.7% | 0.09% | +17.1% |
| Q2 2013 | $232,190,000 | – | 3,668,094 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |